CI
IMMU

Cowen Inc’s Immunomedics Inc IMMU Stock Holding History

Cowen Inc’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$139K Buy
+140,000
New +$2.11M 0.01% 278
2015
Q3 		– Sell
-5,000
Closed -$2K – 469
2015
Q2 		$2K Buy
+5,000
New +$20.4K ﹤0.01% 462

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Cowen Inc's IMMU Position: Q2 2019 in Review

Cowen Inc opened a new position in Immunomedics Inc (IMMU) in Q2 2019: 14,611 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #246 among its holdings. This is a return to the name: Cowen Inc previously reported a position in IMMU as recently as Q2 2018.

Cowen Inc first reported a position in IMMU in Q1 2015 and has held it in 3 quarters since. 204 funds tracked by Wall St. Rank hold IMMU as of Q2 2019.

  • Cowen Inc held 14,611 shares of Immunomedics Inc worth $203K as of Q2 2019.
  • Immunomedics Inc was a new Cowen Inc position in Q2 2019.
  • Immunomedics Inc made up 0.01% of Cowen Inc's portfolio in Q2 2019, its #246 holding.
  • Cowen Inc first reported a position in Immunomedics Inc in Q1 2015 and has held it in 3 quarters since.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.